Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption
- PMID: 23184503
- DOI: 10.1177/1352458512468498
Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption
Comment on
-
Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal.Mult Scler. 2012 Nov;18(11):1647-9. doi: 10.1177/1352458512458009. Epub 2012 Aug 20. Mult Scler. 2012. PMID: 22907938
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources